1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Respiratory Disorders Therapeutics Market to 2017 - Novel
Pipeline Molecules such as VX-770 and pirfenidone May Offset
Negative Effect of Patent Expiries
http://www.aarkstore.com/reports/Respiratory-Disorders-Therapeutics-
Market-to-2017-Novel-Pipeline-Molecules-such-as-VX-770-and-pirfenidone-
May-Offset-Negative-Effect-of-Patent-Expiries-155026.html
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Company Research, the leading business intelligence provider, has released its latest
research, “Respiratory Disorders Therapeutics Market to 2017 - Novel Pipeline
Molecules such as VX-770 and pirfenidone May Offset Negative Effect of Patent
Expiries”, which provides insights into the global respiratory disorders market and
market forecast until 2017. The report provides an in-depth analysis of the top
seven respiratory disorders indications, which includes asthma, COPD, pulmonary

2. arterial hypertension, idiopathic pulmonary fibrosis, allergic rhinitis, cystic fibrosis
and bronchitis. In addition, the report also includes insights into the respiratory
disorders R&D pipeline. Company research analysis estimated that 55% of the
revenues are generated by AstraZeneca, GSK, Novartis, Merck, Roche, UCB Inc,
Actelion and Takeda. Other companies generate 45% of the revenues in the
respiratory disorders therapeutics market. AstraZeneca is the leading company in
the respiratory disorders therapeutics market. The large amount of fragmentation
in the market provides significant scope for consolidation through mergers and
acquisitions. Strategic through acquisition accounted for 53% of the M&A deals.
Scope
- The report analyzes market characterization, pipeline analysis and key M&A
trends in the asthma, COPD, pulmonary arterial hypertension, idiopathic pulmonary
fibrosis, allergic rhinitis, cystic fibrosis and bronchitis therapeutics market.
- Data and analysis on the global respiratory disorders market in the leading
geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
- Annualized market data for the respiratory disorders market from 2002-2010 with
forecasts to 2017.
Table of Contents :
1.1 List of Tables 6
1.2 List of Figures 10
2 Respiratory Disorders Therapeutics Market to 2017 - Introduction 13
2.1 GBI Research Report Guidance 14
3 Respiratory Disorders Therapeutics Market to 2017 - Market Overview 15
3.1 Introduction 15
3.2 Revenue Forecasts for Respiratory Disorders Therapeutics Market 15
3.2.1 Revenues 15
3.2.2 Annual Cost of Therapy 20
3.3 Treatment Usage Patterns 21
3.4 Drivers and Barriers for Respiratory Disorders Therapeutics Market 23
3.4.1 Drivers for Respiratory Disorders 23
3.4.2 Barriers for Respiratory Disorders 24

3. 4 Respiratory Disorders Therapeutics Market to 2017 - Geographical Landscape 25
4.1 The US 25
4.1.1 Revenue 25
4.1.2 Annual Cost of Therapy 26
4.1.3 Treatment Usage Pattern 27
4.2 Top Five Countries of Europe 29
4.2.1 Revenue 29
4.2.2 Annual Cost of Therapy 32
4.2.3 Treatment Usage Pattern 33
4.3 Japan 35
4.3.1 Revenue 35
4.3.2 Annual Cost of Therapy 36
4.3.3 Treatment Usage Pattern 37
5 Respiratory Disorders Therapeutics Market to 2017 - Therapeutic Landscape 39
5.1 Asthma 39
5.1.1 Introduction 39
5.1.2 Revenue 39
5.1.3 Annual Cost of Therapy 44
5.1.4 Treatment Usage Patterns 45
5.1.5 Treatment Flow Algorithm 47
5.1.6 Drivers and Barriers for Asthma 48
5.2 COPD 50
5.2.1 Introduction 50
List of Figures
List of Tables are also include.
For more Discounted Reports Plz follow The link:
Spinal Surgery Devices Market - Global Pipeline Analysis, Competitive Landscape
and Market Forecasts to 2017 - Motion Preserving Spinal Non-Fusion Procedures to

4. Drive Long Term Growth
Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices,
Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic
Surgery Market
Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and
Treatment of Metastatic Cancers to Drive Drug Development
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/market-sector-reports/Pharmaceuticals-&-Healthcare-
7.html
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests,
Biomarkers and Quality of Life Questionnaires All Play Prominent Roles
Respiratory Disorders Therapeutics Market to 2017 - Novel Pipeline Molecules such
as VX-770 and pirfenidone May Offset Negative Effect of Patent Expiries
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com